1 |
Xie L, Qi X, Wang X, He B, Wang Y, Zhang W, Yu Z, Deng M, Liang S, Lü M. Adverse event profiles of adjuvant treatment with opicapone in Parkinson's disease: A systematic review and meta-analysis. Front Pharmacol 2022;13:1042992. [PMID: 36506576 DOI: 10.3389/fphar.2022.1042992] [Reference Citation Analysis]
|
2 |
Szász JA, Constantin VA, Orbán-kis K, Bancu LA, Bataga SM, Ciorba M, Nagy E, Neagoe MR, Mihály I, Szász RM, Kelemen K, Simu M, Szatmári S. Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience. Pharmaceutics 2022;14:1115. [DOI: 10.3390/pharmaceutics14061115] [Reference Citation Analysis]
|